Silverback Therapeutics, Inc.
SEC CIK 1671858 · SPRY · last insider filing 2026-06-26
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Schneider Phillip M | Director | filed 2022 - 2026 |
| Saunders Brent L | Director | filed 2022 - 2026 |
| RA Capital Healthcare Fund LP | Director | filed 2022 - 2026 |
| RA Capital Management, LLC | Director | filed 2022 - 2026 |
| Thompson Peter A. | Director | filed 2020 - 2026 |
| Kolchinsky Peter | Director | filed 2022 - 2026 |
| Shawver Laura | Director · Chief Executive Officer | filed 2020 - 2026 |
| Islam Saqib | Director | filed 2020 - 2026 |
| Shah Pratik | Director | filed 2022 - 2026 |
| Shah Rajeev M. | Director | filed 2022 - 2026 |
| RA Capital Nexus Fund II, L.P. | Director | filed 2022 - 2026 |
| Dadoo Rajeev | Director | filed 2022 - 2026 |
| Kelly Michael | Director | filed 2022 - 2026 |
| Lowenthal Richard E | Director · President and CEO | filed 2022 - 2026 |
| Deerfield Management Company, L.P. (Series C) | Director | filed 2022 - 2025 |
| Flynn James E | Director | filed 2022 - 2025 |
| Deerfield Private Design Fund III, L.P. | Director | filed 2022 - 2025 |
| Deerfield Mgmt III, L.P. | Director | filed 2022 - 2025 |
| Deerfield Private Design Fund IV, L.P. | Director | filed 2022 - 2025 |
| Deerfield Mgmt IV, L.P. | Director | filed 2022 - 2025 |
| Orbimed Advisors LLC | Director | filed 2020 - 2024 |
| Orbimed Capital LLC | Director | filed 2020 - 2024 |
| Orbimed Capital GP VI LLC | Director | filed 2020 - 2024 |
| Leff Jonathan S | Director | filed 2022 - 2022 |
| Root Jonathan D | Director | filed 2020 - 2022 |
| Capps Vickie L | Director | filed 2020 - 2022 |
| Hershberg Robert | Director | filed 2020 - 2022 |
| Powell Andrew Kenneth William | Director | filed 2020 - 2022 |
| Koehler Maria | Director | filed 2021 - 2022 |
| Schroeder Thilo | Director | filed 2020 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Fitzpatrick Alexander A | Chief Legal Officer | filed 2022 - 2026 |
| Karas Eric | Chief Commercial Officer | filed 2022 - 2026 |
| Casale Donn | President | filed 2026 - 2026 |
| Dorsey Brian | Chief Operating Officer | filed 2022 - 2026 |
| Scott Kathleen D. | Chief Financial Officer | filed 2022 - 2026 |
| Chakma Justin | Chief Business Officer | filed 2022 - 2026 |
| Tanimoto Sarina | Chief Medical Officer | filed 2022 - 2026 |
| Pepe Jeffrey C. | Interim CEO and GC | filed 2022 - 2022 |
| Hawkinson Russ | Sr. Vice President of Finance | filed 2020 - 2022 |
| Piazza Jonathan | Chief Financial Officer | filed 2020 - 2022 |
| Hunder Naomi | Chief Medical Officer | filed 2020 - 2022 |
| Odegard Valerie | President and CSO | filed 2020 - 2022 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.